Role of statins in aortic valve disease.
Rajamannan
Nalini M
NM
Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. n-rajamannan@northwestern.edu
D000818:Animals; D001024:Aortic Valve Stenosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D015415:Biomarkers / Q000378:metabolism; D002114:Calcinosis / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D004195:Disease Models, Animal; D004341:Drug Evaluation; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D026502:LDL-Receptor Related Proteins / Q000378:metabolism; D050356:Lipid Metabolism / Q000187:drug effects; D011817:Rabbits; D012307:Risk Factors; D016896:Treatment Outcome
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D026502:LDL-Receptor Related Proteins